Botanisol is a translational biopharmaceuticals company that develops safer drugs and other healthcare products through limited, value enhancing R&D applied to previously recognized bioactive constituents of plants. The firm's mission is to further the development of promising but often overlooked scientific advances, mainly from academic research. We sell the enhanced, IP-protected technologies into well funded development pipelines of pharmaceutical and healthcare companies.Botanisol LLC was formed to commercialize a promising bioactive compound discovered at the University of Arizona. The firm holds the exclusive license to the patented technology.The turmeric-based drug could be a possible replacement for non-steroidal anti-inflammatory drugs such as Ibuprofen, aspirin and naproxen.
